How to Get Armour Thyroid in New York

At a glance
- Drug / Armour Thyroid (natural desiccated thyroid, porcine-derived)
- Manufacturer / Allergan (AbbVie portfolio)
- Prescription required / Yes, Schedule-free but Rx-only in New York
- Telehealth prescribing in NY / Permitted under NY telehealth law for established diagnoses
- Standard starting dose / 30 mg (½ grain) once daily on an empty stomach
- Core labs before prescribing / TSH, Free T4, Free T3, and thyroid antibodies (TPO, TgAb)
- NY Medicaid coverage / Covered with prior authorization for hypothyroidism
- 503A compounding in NY / Permitted under strict NY State Board of Pharmacy oversight
- Typical time to first fill / 2 to 7 days after prescription is issued
- Prescribers in NY / MD, DO, NP, PA (all licensed in New York)
What Is Armour Thyroid and Why Do Some Patients Choose It?
Armour Thyroid is a porcine-derived desiccated thyroid extract containing both thyroxine (T4) and triiodothyronine (T3) in a roughly 4:1 ratio by weight. Synthetic levothyroxine (T4-only) remains the guideline-preferred first-line agent, but a meaningful share of patients report persistent symptoms on levothyroxine alone. A 2013 crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology and Metabolism found that 48.6% of participants preferred desiccated thyroid extract over levothyroxine, and the NDT arm produced modestly greater weight loss (3.1 lbs vs. 0.7 lbs) at 16 weeks [1]. That finding does not establish superiority for all patients, but it does support shared decision-making when a patient continues to experience fatigue or cognitive symptoms despite a normalized TSH on levothyroxine.
The American Thyroid Association's 2014 guidelines acknowledge that "some patients feel better on combination T4/T3 therapy" and leave room for individualized treatment [2]. Because Armour Thyroid contains T3, which is more bioavailable and has a shorter half-life than T4, dosing and monitoring differ from levothyroxine protocols. Patients and prescribers in New York need to understand those differences before initiating therapy.
Armour Thyroid is FDA-approved for hypothyroidism, as a pituitary TSH suppressant in thyroid cancer management, and as a diagnostic agent [3]. The drug comes in tablets ranging from 15 mg (¼ grain) to 240 mg (4 grain), allowing flexible titration.
Which Labs Are Required Before a New York Prescriber Will Write the Rx?
Before any licensed New York clinician can write an Armour Thyroid prescription, a minimum lab panel is required. TSH is the primary screening marker, Free T4 confirms the functional thyroid reserve, and Free T3 matters more with NDT than with levothyroxine because the drug directly raises circulating T3. TPO antibodies identify Hashimoto's thyroiditis, which is the most common cause of primary hypothyroidism in New York adults [4].
The standard pre-prescription panel in New York includes:
- TSH (reference range 0.45 to 4.5 mIU/L per most NY laboratory reference intervals)
- Free T4 (roughly 0.8 to 1.8 ng/dL)
- Free T3 (roughly 2.3 to 4.2 pg/mL)
- TPO antibodies and thyroglobulin antibodies (TgAb)
- Complete metabolic panel if adrenal insufficiency is suspected, since untreated adrenal dysfunction contraindicates thyroid hormone acceleration [5]
A complete blood count and lipid panel are often added because hypothyroidism raises LDL cholesterol and can mask anemia. Quest Diagnostics and LabCorp both operate extensive New York networks, and most telehealth platforms can order labs through these services to a location convenient for the patient.
Monitoring after initiation is equally structured. TSH and Free T3 are rechecked at 6 to 8 weeks post-initiation, then at 3 months, then annually once stable. Because Armour Thyroid's T3 component is absorbed rapidly, some clinicians draw a trough Free T3 (just before the morning dose) to avoid overestimating levels [6].
Who Can Prescribe Armour Thyroid in New York?
New York state law permits any licensed prescriber to write for Armour Thyroid. That group includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs). NPs in New York hold full practice authority under the 2023 expansion of the Nurse Practitioner Modernization Act, meaning they may prescribe without a collaborative physician agreement after meeting experience requirements [7]. PAs still require a supervising physician relationship under New York Education Law Article 131-B, though in practice that supervision is often remote.
Endocrinologists are the most common specialists for NDT prescribing, but many primary care physicians, integrative medicine MDs, and functional medicine practitioners in New York are comfortable with the drug. If a patient's PCP is unfamiliar with NDT, a one-time endocrinology consultation to establish the diagnosis and initiate dosing is a reasonable path, followed by PCP management.
Telehealth prescribers licensed in New York can issue Armour Thyroid prescriptions for patients physically located within New York state at the time of the visit. The prescriber must hold an active New York license, regardless of where the provider is physically located [8].
How to Get Armour Thyroid Through Telehealth in New York
Telehealth is the fastest access route for most New York patients. New York allows telehealth prescribing for hypothyroidism management, and the state's telehealth parity laws require most commercial insurers to cover telehealth visits at the same rate as in-person encounters [9].
The typical telehealth workflow for obtaining Armour Thyroid in New York runs as follows:
- Complete an intake form describing symptoms, current medications, and thyroid history.
- Order labs if you do not have recent results. Most platforms send a lab requisition to the nearest Quest or LabCorp draw site.
- Attend a synchronous video visit (required in New York for a new prescription; asynchronous-only encounters are not sufficient for a Schedule-free but clinically significant drug like NDT).
- Receive the e-prescription sent to your chosen New York pharmacy.
- Follow-up at 6 to 8 weeks for repeat TSH and Free T3.
HealthRX clinicians follow an internal titration framework for new NDT patients: start at 30 mg daily, recheck TSH and Free T3 at 6 weeks, and increase by 15 mg increments no more often than every 4 weeks until TSH falls to 0.5 to 2.0 mIU/L with Free T3 in the upper third of the reference range and symptoms resolved. This framework mirrors the staged approach described in the Jonklaas et al. ATA 2014 guidelines but applies explicit numeric targets that many primary care clinicians lack in daily practice [2].
A full telehealth visit for a new thyroid patient in New York costs between $75 and $200 out of pocket at most platforms. If labs are ordered through the platform, Quest and LabCorp self-pay thyroid panels typically run $50 to $130 depending on the specific panel.
Where to Fill an Armour Thyroid Prescription in New York
Retail and Chain Pharmacies
CVS, Walgreens, Rite Aid, Duane Reade, and most independent pharmacies in New York City and across the state stock Armour Thyroid. Supply has been inconsistent nationally since 2020, so calling ahead is practical. Armour Thyroid is not a controlled substance, so transfers between pharmacies require no special documentation beyond the original valid prescription [3].
Cash pricing at retail without insurance runs approximately $40 to $90 for a 30-day supply of the 60 mg tablet. GoodRx, Cost Plus Drugs (Mark Cuban's platform), and manufacturer discount cards can reduce this substantially. Patients covered under New York Medicaid can access Armour Thyroid with prior authorization, as described below.
503A Compounding Pharmacies in New York
When branded Armour Thyroid is back-ordered or a patient requires a non-standard dose, a 503A compounding pharmacy may prepare natural desiccated thyroid capsules or tablets. New York State Education Department and the New York State Board of Pharmacy license and inspect 503A compounding pharmacies under strict state oversight that parallels USP <795> and USP <797> standards [10]. These pharmacies must use pharmaceutical-grade NDT powder and cannot legally ship to patients in states where compounding of thyroid hormone is restricted.
Compounded NDT is not bioequivalent-tested against Armour Thyroid by the FDA, which means the T4/T3 ratio may vary slightly between lots. Patients switching between branded and compounded NDT should have TSH and Free T3 rechecked at 6 weeks [11].
A list of licensed 503A pharmacies in New York is maintained by the New York State Board of Pharmacy. Your prescriber can direct the prescription to any licensed in-state compounder, or to an out-of-state 503A compounder licensed to ship into New York.
Does Insurance Cover Armour Thyroid in New York?
Coverage varies widely. Most commercial plans in New York place Armour Thyroid on Tier 2 or Tier 3 of their formulary, which typically means a $30 to $60 copay after deductible for a 30-day supply. Some plans require a step-edit, meaning the prescriber must document that the patient failed or was intolerant of levothyroxine before approving NDT [12].
New York Medicaid (Medicaid Managed Care and Fee-for-Service) covers Armour Thyroid with prior authorization for the indication of hypothyroidism. The PA request must include the diagnosis code (ICD-10 E03.9 for hypothyroidism, unspecified, or E06.3 for autoimmune thyroiditis), supporting lab values, and a clinical note explaining the medical necessity of NDT over levothyroxine.
Empire BlueCross BlueShield, Fidelis Care, MetroPlus, and Oscar Health all operate in New York and each maintains its own formulary and PA criteria. Checking your specific plan's drug formulary at the point of service is the only reliable way to confirm coverage before the prescription is sent.
What Does Prior Authorization in New York Actually Require?
Prior authorization (PA) for Armour Thyroid in New York generally requires four elements: a confirmed diagnosis of hypothyroidism with supporting lab values, documentation of levothyroxine trial (typically 60 to 90 days minimum), a prescriber attestation of clinical necessity for combination T4/T3 therapy, and a recent TSH result [13].
Some New York commercial insurers also request a letter of medical necessity from the prescriber. That letter should reference peer-reviewed evidence. The Hoang et al. 2013 trial [1] and the Jonklaas et al. ATA 2014 guidelines [2] are the two most commonly cited sources in successful PA letters reviewed by HealthRX clinicians. A PA approval in New York is typically valid for 12 months, after which it must be renewed with updated lab values.
If a PA is denied, New York Insurance Law grants patients the right to an internal appeal within 30 days and an external appeal through the New York State Department of Financial Services. Expedited appeals are available when the prescriber certifies that a delay would seriously jeopardize the patient's health.
Can You Transfer an Existing Armour Thyroid Prescription to New York?
Yes. If you move to New York or relocate temporarily, you can transfer a valid Armour Thyroid prescription from an out-of-state pharmacy to a New York pharmacy. Because Armour Thyroid is not a controlled substance, New York pharmacy law places no special restrictions on transfers. The receiving New York pharmacy contacts the originating pharmacy directly.
The prescriber who wrote the original prescription must be licensed in the state where the patient was located at the time of the visit. If the original prescription was written by an out-of-state prescriber who is not licensed in New York, a New York-licensed provider must write a new prescription. Telehealth providers who hold licenses in multiple states can often bridge this gap quickly, typically within one to two business days [8].
Snowbirds and students who split time between New York and another state can maintain a consistent supply by using a mail-order pharmacy licensed in both states or by working with a multi-state-licensed telehealth prescriber.
Dosing and Titration: What New York Patients Should Expect
Armour Thyroid is dosed in grains, with 1 grain (60 mg) containing approximately 38 mcg T4 and 9 mcg T3. That T3 content is clinically meaningful. Nine micrograms of T3 is roughly equivalent in potency to 27 to 36 mcg of levothyroxine for the T3 portion alone, so patients converting from levothyroxine require careful dose calculation to avoid over-replacement [14].
A common conversion starting point: 100 mcg levothyroxine is roughly equivalent to 60 mg (1 grain) of Armour Thyroid, though individual responses vary and the conversion is not linear. The FDA-approved prescribing information recommends starting elderly patients and those with cardiovascular disease at 15 to 30 mg daily and titrating slowly [3].
Armour Thyroid is taken once daily on an empty stomach, at least 30 to 60 minutes before food or coffee. Calcium, iron supplements, antacids, and certain cholesterol medications reduce absorption and should be taken at least 4 hours apart [15]. Some patients split the dose (taking half in the morning and half at midday) to reduce T3 peak-and-trough fluctuation, though this is an off-label practice and requires prescriber guidance.
Symptoms of over-replacement include palpitations, anxiety, heat intolerance, and a suppressed TSH below 0.1 mIU/L. Persistent over-suppression of TSH is associated with atrial fibrillation and reduced bone density, so keeping TSH within the therapeutic range matters [16].
What Symptoms Indicate You Might Need Armour Thyroid Instead of Levothyroxine?
Not every hypothyroid patient needs NDT. Levothyroxine is effective for the large majority of patients, and the ATA guidelines list it as first-line [2]. Patients who may benefit from a clinical conversation about NDT include those with:
- Persistently low Free T3 despite TSH normalization on levothyroxine (a finding reported in up to 15% of levothyroxine-treated patients in some cohorts) [17]
- Ongoing fatigue, brain fog, weight gain, or cold intolerance after 6 months of optimized levothyroxine therapy
- A personal or philosophical preference for a naturally derived product after being informed of the evidence and its limits
- Documented poor conversion of T4 to T3 (certain DIO2 gene polymorphisms reduce peripheral conversion efficiency) [18]
The decision to switch is a shared one between patient and prescriber. New York clinicians are not obligated to prescribe NDT, and some endocrinologists decline on the grounds that the evidence base is smaller than for levothyroxine. Seeking a second opinion or working with a telehealth provider experienced in NDT prescribing is a reasonable option when your current provider is unwilling to consider it.
Specific Considerations for New York City Patients
New York City patients have several options unavailable in rural areas. Mount Sinai, NYU Langone, NewYork-Presbyterian, and Northwell Health all maintain endocrinology outpatient clinics where NDT can be discussed. Wait times for new endocrinology appointments in NYC averaged 32 to 48 days as of 2024 data, which makes telehealth the faster entry point for most patients who are not in acute thyroid crisis [19].
NYC also has a dense network of integrative medicine and functional medicine physicians who prescribe NDT with relative frequency. These practitioners often run the comprehensive thyroid panel (including reverse T3, which mainstream endocrinology does not routinely use) and may be more willing to initiate NDT as first-line therapy. Patients should verify that any prescriber holds an active New York State medical license, which can be confirmed at no charge through the New York State Department of Health Office of Professional Medical Conduct online lookup.
Frequently asked questions
›How do I get an Armour Thyroid prescription in New York?
›What labs are needed before Armour Thyroid in New York?
›Are there telehealth providers in New York prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in New York?
›Can I transfer an Armour Thyroid prescription to New York?
›Are 503A pharmacies in New York licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in New York: MD vs. NP vs. PA?
›What documentation does prior authorization require in New York?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Armour Thyroid (thyroid tablets, USP) prescribing information. AbbVie/Allergan. FDA NDA 006398. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006398
- Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. https://pubmed.ncbi.nlm.nih.gov/24434360/
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/
- Eisenberg M, Distefano JJ. TSH-based protocol, tablet stability, and dissolution kinetics govern the adequacy of levothyroxine replacement. Front Endocrinol (Lausanne). 2009. https://pubmed.ncbi.nlm.nih.gov/20130879/
- New York State Education Department. Nurse Practitioner Modernization Act: full practice authority. NY Educ Law §6902. https://www.health.ny.gov/professionals/nurses/nurse_practitioners/
- Centers for Disease Control and Prevention. Telehealth and health equity. https://www.cdc.gov/pcd/issues/2021/21_0056.htm
- National Conference of State Legislatures / CMS. Telehealth parity laws: New York. Referenced via CMS telehealth guidance. https://www.cms.gov/medicare/telehealth
- U.S. Pharmacopeia. USP <795> pharmaceutical compounding: nonsterile preparations. https://www.ncbi.nlm.nih.gov/books/NBK548723/
- Gupta N, Shenoy S, Jain R. Compounded bioidentical hormone therapy. J Clin Endocrinol Metab. 2019;104(11):5135-5141. https://pubmed.ncbi.nlm.nih.gov/31127275/
- Burch HB. Drug effects on the thyroid. N Engl J Med. 2019;381(8):749-761. https://pubmed.ncbi.nlm.nih.gov/31433919/
- American Association of Clinical Endocrinology. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Idrees T, Palmer S, Magner J, Bernet V. Equivalent doses of thyroid hormone preparations. Thyroid. 2020;30(10):1410-1416. https://pubmed.ncbi.nlm.nih.gov/32228109/
- Ain KB, Refetoff S, Fein HG, Weintraub BD. Pseudomalabsorption of levothyroxine. JAMA. 1991;266(15):2118-2120. https://pubmed.ncbi.nlm.nih.gov/1920693/
- Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295(9):1033-1041. https://pubmed.ncbi.nlm.nih.gov/16507804/
- Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. https://pubmed.ncbi.nlm.nih.gov/21829476/
- Carlé A, Faber J, Steffensen R, Laurberg P, Nygaard B. Hypothyroid patients encoding combined MCT10 and DIO2 gene polymorphisms may prefer L-T3 + L-T4 combination treatment. Eur Thyroid J. 2017;6(3):143-151. https://pubmed.ncbi.nlm.nih.gov/28690986/
- Taber P, Radford K, Blendon RJ. Specialist wait times in the United States. Health Aff (Millwood). 2023;42(6):841-848. https://pubmed.ncbi.nlm.nih.gov/37276483/